http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106955356-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106955356-B |
| titleOfInvention | Combined medicine composition for treating tumor |
| abstract | The invention provides a combined medicine composition for treating tumors, which comprises effective dose of acyl coenzyme A: a cholesterol acyltransferase ACAT 1inhibitor and an effective amount of dacarbazine. The invention discloses acyl coenzyme A: the cholesterol acyltransferase ACAT 1inhibitor can enhance the killing activity of CD8T cells on tumors, and has synergistic effect when being combined with dacarbazine, thereby further enhancing the inhibition on tumors. |
| priorityDate | 2016-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.